Herbal Monograph
Lemon balm
Melissa officinalis L.
Lamiaceae (Labiatae)
Gentle nervine and cognitive enhancer with antiviral properties for cold sore...
Overview
Plant Description
Lemon balm is a herbaceous perennial growing 30-100 cm (12-40 inches) tall with erect, branching, square stems characteristic of the Lamiaceae family. Leaves are opposite, ovate to heart-shaped (cordate), 3-8 cm long, with crenate-serrate margins and a prominently veined, slightly rugose surface. The leaf surface bears glandular trichomes (oil glands) that release a strong lemon fragrance when crushed. Flowers are small (8-15 mm), bilabiate, white to pale yellow or pinkish, borne in loose axillary verticillasters of 3-12 flowers in the upper leaf axils. Fruit consists of four smooth, dark brown nutlets. The plant spreads vigorously via rhizomes and can form dense colonies. The genus name 'Melissa' derives from the Greek word for 'honeybee' (melitta/melissa), reflecting the plant's long reputation as a superior bee forage -- Pliny the Elder noted that bees were especially attracted to it.
Habitat
Native to the eastern Mediterranean region, western Asia, and southern Europe. Thrives in moist but well-drained, humus-rich soils in partial shade to full sun. Commonly found in hedgerows, woodland margins, disturbed ground, and garden settings. Tolerates a range of soil pH (5.0-7.5) but prefers slightly acidic to neutral conditions. Naturalised widely in northern Europe, the British Isles, and temperate regions of North America where it has escaped cultivation.
Distribution
Indigenous to the Mediterranean basin from the Iberian Peninsula through Turkey and the Caucasus to Iran. Widely cultivated and naturalized across Europe, North and South America, and temperate Asia. Major commercial production in Germany, France, Italy, Romania, Bulgaria, Hungary, Egypt, and Iran. Germany and France are the primary producers of pharmaceutical-grade dried leaf (Melissae folium) for the European market.
Parts Used
Leaves and aerial parts (Melissae folium / Melissae herba)
Preferred: Dried leaves for infusion; hydroethanolic tincture or liquid extract; standardized dry extract (e.g., Cyracos, standardized to rosmarinic acid); essential oil (by steam distillation of fresh herb); fresh leaves for culinary and extemporaneous preparations
The dried leaf is the official drug in the European Pharmacopoeia (Melissae folium, Ph. Eur. 10.0). Commission E, WHO, EMA/HMPC, and ESCOP monographs all specify the leaf or aerial parts collected before flowering. The essential oil content of the leaf is very low (0.02-0.37%), but the majority of the pharmacologically active compounds -- notably rosmarinic acid (0.5-7% of dried leaf), flavonoids, and tannins -- are non-volatile and well-extracted in aqueous and hydroethanolic preparations. Thus whole-leaf preparations (infusion, tincture, extract) provide a broader pharmacological profile than the essential oil alone. The European Pharmacopoeia requires a minimum of 1.0% total hydroxycinnamic acid derivatives calculated as rosmarinic acid.
Key Constituents
Hydroxycinnamic acid derivatives (phenolic acids)
Rosmarinic acid is the single most important pharmacological compound in lemon balm, responsible for or contributing to antiviral (anti-HSV), antioxidant, anti-inflammatory, and anxiolytic activity. It is the primary marker compound for pharmacopeial quality control (Ph. Eur. requires minimum 1.0% total hydroxycinnamic derivatives as rosmarinic acid). The Cyracos standardized extract used in clinical trials (Cases et al. 2011) is standardized to contain more than 7% rosmarinic acid and more than 15% total hydroxycinnamic acid derivatives. Rosmarinic acid is efficiently extracted in both aqueous (infusion) and hydroethanolic (tincture) preparations.
Essential oil (mono- and sesquiterpenoids)
Despite the very low essential oil content of the dried leaf (0.02-0.37%), the terpenoid fraction contributes to the sedative, antispasmodic, carminative, and antimicrobial activity of lemon balm. Multiple chemotypes are recognized based on the ratio of citral to citronellal. The essential oil has demonstrated potent in vitro antiviral activity against HSV-1 and HSV-2 (Schnitzler et al. 2008), likely through direct virucidal action on the viral envelope. CRITICAL NOTE: Due to the extremely low essential oil yield, genuine Melissa officinalis essential oil is one of the most expensive commercially available essential oils, and adulteration with cheaper lemongrass (Cymbopogon citratus) or citronella (Cymbopogon nardus) oils is widespread. Authentication by GC-MS profiling is essential for quality assurance.
Flavonoids
Flavonoids contribute to the anxiolytic, sedative, antioxidant, and anti-inflammatory activity of lemon balm. Luteolin's inhibition of GABA transaminase is a proposed mechanism by which lemon balm enhances GABAergic neurotransmission, complementing the direct GABA-A receptor binding activity of apigenin. Total flavonoid content is lower than in chamomile, but the synergistic interaction with rosmarinic acid and terpenoid constituents produces a clinically relevant nervine and anxiolytic effect.
Triterpenic acids
Triterpenic acids contribute modestly to the anti-inflammatory and antimicrobial profile of lemon balm. Their role is secondary to rosmarinic acid and the essential oil fraction.
Tannins
Tannins contribute to the mild astringent action of lemon balm and supplement the antiviral activity of rosmarinic acid. The tannin fraction may enhance the topical antiherpetic effect by forming a protective barrier on mucosal surfaces.
Herbal Actions
Supports and calms the nervous system
Nervine relaxant and trophorestorative. Lemon balm calms nervous excitability and restores tone to the nervous system. Commission E approved for 'nervous sleeping disorders' and 'functional gastrointestinal complaints' (reflecting the nerve-gut axis). EMA classifies the anxiolytic/nervine indication as well-established use. The mechanism involves multiple pathways: rosmarinic acid modulates GABAergic neurotransmission; luteolin inhibits GABA transaminase (increasing synaptic GABA availability); apigenin binds GABA-A benzodiazepine receptors; and essential oil terpenoids (linalool, citral) contribute to CNS-depressant effects. Historically considered one of the premier nervine herbs in Western herbal tradition -- Culpeper (1653) wrote that it 'driveth away all troublesome cares and thoughts out of the mind.'
[1, 3, 6, 7]Reduces anxiety
Clinical evidence for anxiolytic activity from multiple trials. Kennedy et al. (2004) demonstrated that 600 mg Melissa extract significantly attenuated the negative mood effects of a defined laboratory stressor (DISS) in healthy volunteers. Cases et al. (2011) found that Cyracos extract (600 mg/day, standardized to more than 7% rosmarinic acid) reduced anxiety manifestations by 18% and anxiety-associated symptoms by 15% in a 15-day pilot study. Scholey et al. (2014) confirmed anti-stress effects with a lemon balm-containing preparation. The anxiolytic action is considered clinically milder than pharmaceutical anxiolytics but is well-suited for mild-to-moderate anxiety, particularly when accompanied by somatic digestive symptoms.
[7, 8, 10, 14]Relieves smooth muscle spasm
Smooth muscle relaxant action primarily mediated by the essential oil constituents (citral, citronellal) and flavonoids. Commission E approved for 'functional gastrointestinal complaints,' reflecting the antispasmodic activity on GI smooth muscle. ESCOP and EMA recognize the antispasmodic indication. The mechanism involves both direct smooth muscle relaxation and modulation of cholinergic muscarinic receptor signaling. Particularly indicated for GI spasm associated with nervous tension ('nervous stomach').
[1, 3, 4, 6]Relieves intestinal gas and bloating
The volatile oil components relieve intestinal gas and bloating through combined antispasmodic and prokinetic effects. One of the traditional 'four carminative seeds and balm' combinations in European herbal medicine. Commission E recognized the carminative action within the functional GI indication. Often combined with other carminatives (fennel, peppermint, chamomile) in proprietary formulations for infant colic (e.g., ColiMil -- Savino et al. 2005) and adult dyspepsia.
[1, 5, 6, 15]Prevents or slows oxidative damage to cells
High rosmarinic acid content provides potent radical-scavenging activity. Rosmarinic acid inhibits lipid peroxidation and scavenges superoxide anion, hydroxyl radical, and peroxyl radicals. Total antioxidant capacity of lemon balm aqueous extract is among the highest of commonly used Lamiaceae herbs (comparable to rosemary). The antioxidant activity contributes to the neuroprotective and anti-inflammatory effects observed in clinical and preclinical studies.
[3, 22]Kills or inhibits the growth of microorganisms
Demonstrates significant antiviral activity, particularly against herpes simplex virus types 1 and 2 (HSV-1, HSV-2). Schnitzler et al. (2008) showed that Melissa essential oil exhibited potent virucidal activity against HSV in vitro, primarily through direct inactivation of free virus particles before host cell attachment. Rosmarinic acid inhibits viral entry by interfering with glycoprotein-mediated attachment. Koytchev et al. (1999) demonstrated clinical efficacy of topical 1% Melissa extract cream (Lo-701/Lomaherpan) for recurrent herpes labialis, with significant reduction in symptom scores and healing time. The essential oil also demonstrates moderate in vitro activity against gram-positive bacteria (S. aureus, B. subtilis) and Candida spp.
[12, 19, 22]Promotes sleep and deep relaxation
Mild sedative action at standard doses, with enhanced effect at higher doses or in combination preparations. Cases et al. (2011) found Cyracos extract reduced insomnia by 42% over 15 days. Cerny and Schmid (1999) demonstrated that a combination of valerian (160 mg) and lemon balm (80 mg) improved sleep quality comparably to low-dose triazolam (0.125 mg) in healthy volunteers. The sedative effect is most pronounced when insomnia is secondary to anxiety or mental overactivity. Often combined with valerian, passionflower, or hops for enhanced sleep support in European phytotherapy.
[6, 7, 13]Enhances cognitive function, memory, and mental performance
Enhances cognitive function, memory, and attention. Kennedy et al. (2002) RCT demonstrated that single doses of 600 mg dried leaf improved accuracy of attention and memory task performance in healthy young adults. Kennedy et al. (2003) confirmed cholinergic receptor-binding properties (nicotinic and muscarinic) in vitro and correlated these with cognitive enhancement in vivo. Akhondzadeh et al. (2003) RCT found significant improvement in cognitive function (ADAS-cog scores) and reduced agitation in patients with mild-to-moderate Alzheimer's disease over 4 months. The nootropic mechanism involves inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) by rosmarinic acid and terpenoid constituents, increasing cholinergic neurotransmission.
[8, 9, 11, 21]Promotes perspiration
Traditional use as a mild diaphoretic in febrile conditions, particularly in children. Lemon balm tea (often combined with elderflower or peppermint) is a traditional European febrifuge for common colds and influenza. The diaphoretic action is considered gentle and safe for pediatric use. Hoffmann describes lemon balm as a 'gentle diaphoretic suitable for children's fevers.'
[6, 16]Stimulates or increases menstrual flow
Traditional use to promote menstrual flow and ease dysmenorrhea, documented in European folk medicine and the Eclectic tradition. The antispasmodic and nervine actions may contribute to relief of menstrual discomfort. No strong clinical evidence for direct emmenagogue activity. King's American Dispensatory (1898) listed lemon balm for 'suppressed menstruation.'
[16, 17]Reduces inflammation
Rosmarinic acid inhibits complement C3 convertase activation and 5-lipoxygenase, reducing leukotriene synthesis. Ursolic acid and oleanolic acid contribute additional anti-inflammatory activity. The anti-inflammatory effect is moderate compared to dedicated anti-inflammatory herbs (turmeric, boswellia) but contributes meaningfully to the overall therapeutic profile, particularly for inflammatory digestive conditions and topical skin applications.
[3, 22]Therapeutic Indications
Nervous System
Anxiety and restlessness (mild to moderate)
Commission E approved indication for 'nervous sleeping disorders.' EMA well-established use for 'relief of mild symptoms of mental stress and to aid sleep.' Cases et al. (2011) pilot RCT: Cyracos extract (600 mg/day) reduced anxiety manifestations by 18% and anxiety-associated symptoms by 15% in 20 volunteers over 15 days. Kennedy et al. (2004) RCT demonstrated significant attenuation of laboratory-induced stress with 600 mg Melissa extract. Multiple mechanisms converge: GABAergic modulation (rosmarinic acid, luteolin, apigenin), cholinergic receptor modulation, and direct terpenoid CNS effects.
[1, 3, 7, 10]Insomnia (mild, especially associated with anxiety or mental overactivity)
Cases et al. (2011): Cyracos extract reduced insomnia by 42% over 15 days. Cerny and Schmid (1999): Combination of valerian (160 mg) and lemon balm (80 mg) improved sleep quality comparably to triazolam 0.125 mg. Commission E and EMA recognize the sleep-promoting indication. Lemon balm is most effective for insomnia characterized by mental hyperactivity and difficulty 'switching off' at bedtime rather than for maintaining sleep.
[1, 7, 13]Cognitive function and memory enhancement
Kennedy et al. (2002) dose-ranging crossover RCT in 20 healthy young adults: single doses of 600 mg improved accuracy of attention and calmness ratings. Kennedy et al. (2003) confirmed cholinergic receptor-binding properties correlating with cognitive enhancement. The nootropic effect is attributed primarily to inhibition of acetylcholinesterase by rosmarinic acid and terpenoid constituents, increasing cholinergic neurotransmission. Effect size is moderate; most clinical evidence is for acute single-dose administration rather than chronic use in healthy populations.
[8, 9, 21]Mild-to-moderate Alzheimer's disease (adjunctive)
Akhondzadeh et al. (2003) double-blind, placebo-controlled RCT: 42 patients with mild-to-moderate Alzheimer's disease received Melissa officinalis extract (60 drops/day) or placebo for 16 weeks. The Melissa group showed significantly better outcomes on ADAS-cog (cognitive subscale, P < 0.01) and CDR (Clinical Dementia Rating, P < 0.01), with reduced agitation. Mechanism: AChE inhibition by rosmarinic acid and terpenoids. This is a single small trial requiring replication in larger multi-center studies before clinical recommendations can be made.
[11, 21]ADHD-associated restlessness and hyperactivity (pediatric, adjunctive)
Limited preliminary evidence from open-label studies and traditional use suggest lemon balm (often in combination with valerian) may reduce hyperactivity and improve concentration in children with ADHD. The gentle nervine and anxiolytic profile makes it a candidate for further investigation. No large-scale RCTs specific to ADHD as primary indication have been published. Use should be considered adjunctive and under professional guidance.
[6, 22]Nervous tension headache
Traditional European use for headaches associated with nervous tension and stress. The combined nervine, anxiolytic, and mild antispasmodic actions provide a rational basis for this indication. Often used in combination with lavender, peppermint, or feverfew for tension headache. No specific clinical trials for lemon balm as a standalone headache treatment.
[6, 16]Digestive System
Functional dyspepsia and nervous stomach
Commission E approved indication for 'functional gastrointestinal complaints.' EMA well-established traditional use for 'symptomatic relief of digestive disorders such as minor spasms.' The combination of carminative, antispasmodic, and nervine actions makes lemon balm specifically indicated for dyspeptic symptoms with a nervous or stress-related component -- the gut-brain axis herb. Often combined with peppermint, chamomile, or fennel in compound digestive formulas.
[1, 3, 5]Infant colic (in combination with chamomile and fennel)
Savino et al. (2005) double-blind, placebo-controlled RCT: A standardized extract of Matricaria recutita, Foeniculum vulgare, and Melissa officinalis (ColiMil) given twice daily for 7 days reduced crying time in 85.4% of infants vs 48.9% placebo (P < 0.005). Mean daily crying time decreased from 201 to 77 minutes/day. Lemon balm was one component; effects cannot be attributed to it specifically, but its inclusion is pharmacologically rational given the carminative and antispasmodic properties.
[15]Immune System
Herpes simplex labialis (cold sores) -- topical
Koytchev et al. (1999) double-blind, placebo-controlled RCT (n=116): Topical 1% lemon balm extract cream (Lo-701/Lomaherpan) applied four times daily significantly reduced symptom scores from day 2 of treatment (P < 0.01) and shortened healing time compared to placebo. The product is marketed in Germany as Lomaherpan and is widely used for recurrent herpes labialis. Schnitzler et al. (2008) demonstrated potent in vitro virucidal activity of Melissa essential oil against HSV-1 and HSV-2, with inhibitory concentrations well below cytotoxic levels. The mechanism involves inhibition of viral attachment and entry through interaction with viral surface glycoproteins.
[12, 19]Cardiovascular System
Stress-related palpitations and nervous heart
Traditional European and Persian use for heart palpitations associated with anxiety and emotional distress. Avicenna recommended lemon balm to 'make the heart merry' and for 'palpitation due to dark humours.' The English common name 'Heart's delight' reflects this cardiotropic tradition. The anxiolytic and nervine actions provide a plausible mechanism for functional palpitation relief. No direct clinical evidence for antiarrhythmic or specific cardiac effects.
[6, 16, 18]Endocrine System
Thyroid modulation (Graves' disease adjunct)
Auf'mkolk et al. (1985) demonstrated in vitro that Melissa officinalis extract and specific oxidized phenolic compounds inhibit the binding of TSH receptor antibodies (characteristic of Graves' disease) to thyroid membrane preparations. The mechanism involves oxidized derivatives of rosmarinic acid and other phenolics that interfere with TSH receptor-immunoglobulin interaction. This is predominantly in vitro evidence; no controlled clinical trials in Graves' disease patients have been published. Some herbalists use lemon balm as part of a formula for mild hyperthyroidism, but this should only be done under professional supervision and should not replace standard endocrine care.
[20, 22]Skin / Integumentary
Herpes labialis (cold sores) -- topical cream
Topical application of 1% lemon balm extract cream (Lomaherpan) is an established treatment in German phytotherapy for recurrent herpes labialis. See the immune system entry for clinical trial details (Koytchev et al. 1999). The preparation is applied at the earliest signs of recurrence (prodromal tingling) for optimal efficacy. Well tolerated with no reported skin irritation or sensitization.
[12]Minor wounds and skin irritation (topical)
Traditional use of lemon balm poultices and washes for minor wounds, insect bites, and skin irritation. The anti-inflammatory (rosmarinic acid), mild antimicrobial, and tannin-based astringent properties provide a rational basis. Limited specific clinical evidence for wound healing as a primary indication.
[6, 16]Energetics
Temperature
cool
Moisture
slightly dry
Taste
Tissue States
hot/excitation, wind/tension, damp/stagnation
Lemon balm is classified as cool and slightly drying in Western herbal energetics. Its cooling, calming nature makes it specific for conditions involving nervous excitation and heat -- anxiety with restlessness, irritability, nervous palpitations, and flushed agitation. The aromatic quality indicates affinity for the digestive system, particularly when GI disturbance accompanies nervous tension ('nervous stomach,' 'butterflies'). The sour taste reflects the high content of phenolic acids, especially rosmarinic acid. The sweet undertone reflects the plant's gentle, palatable character, making it one of the most pleasant-tasting nervine herbs and highly suitable for children and sensitive constitutions. In the Unani tradition, Avicenna classified lemon balm (badranjbuyah) as warm and dry in the second degree, and prescribed it for melancholy and to 'make the heart merry.' Most modern Western herbalists (Hoffmann, Holmes, Wood) classify it as cooling, reflecting its use for hot, agitated, tense tissue states. The combination of nervine and carminative qualities positions lemon balm as a key herb for the gut-brain axis -- soothing nervous tension that manifests simultaneously in the mind and the gut. CAVEAT: Herbal energetics are interpretive frameworks within Western herbalism, not standardized across all practitioners.
Traditional Uses
Ancient Greek and Roman medicine
- Theophrastus (c. 300 BCE) mentioned 'melissophyllon' (bee-leaf) as a plant highly attractive to bees
- Dioscorides (De Materia Medica, 1st century CE) recommended lemon balm for scorpion stings and dog bites, and as a menstrual promoter
- Pliny the Elder noted its use for melancholy, nervous disorders, and as a wound herb
- Used in baths and as a strewing herb for its pleasant scent
"The Greek name 'melissophyllon' (bee-leaf) reflects the long-standing association between lemon balm and beekeeping. Dioscorides recommended it steeped in wine for scorpion stings. The plant was cultivated in the gardens of the Temple of Diana at Ephesus."
Arabic and Persian medicine (Unani Tibb)
- Avicenna (Ibn Sina, 980-1037 CE) prescribed lemon balm (badranjbuyah) in The Canon of Medicine for melancholy, to strengthen the heart, and to 'make the heart merry'
- Used for palpitations and nervous cardiac complaints
- Prescribed as a tonic for the brain and memory
- Combined with other herbs for digestive complaints and flatulence
"Avicenna wrote in The Canon of Medicine (c. 1025 CE): 'It causeth the mind and heart to become merry and it strengtheneth the vital spirits.' He classified it as warm and dry in the second degree and recommended it for depression, cardiac anxiety, and digestive weakness."
European folk medicine (medieval to modern)
- Paracelsus (1493-1541) called lemon balm the 'elixir of life' and believed it could revitalize the entire body
- Carmelite Water (Eau de Carmes/Spiritus Melissae compositus) -- a famous medicinal preparation first distilled by Carmelite monks in Paris in 1611 from lemon balm, lemon zest, nutmeg, and angelica root, used as a nerve tonic and general restorative for over 400 years
- Culpeper (1653) recommended it for 'all complaints which derive from a disordered state of the nervous system' and wrote that it 'driveth away all troublesome cares and thoughts out of the mind'
- John Gerard (1597) recorded it for heart complaints, melancholy, and as a wound herb
- Widely used as a calming tea for children's nervousness, teething pain, and mild fevers
- Added to bath water for nervous tension and insomnia
- Hair rinse and cosmetic applications for skin
"Lemon balm has been cultivated in European monastic gardens since at least the 9th century. Charlemagne (c. 812 CE) ordered it grown in every imperial garden (Capitulare de Villis). The London Dispensatory (1696) stated that 'an essence of Balm, given in Canary wine, every morning, will renew youth, strengthen the brain, relieve languishing nature, and prevent baldness.' Carmelite Water remained an official preparation in French pharmacopoeias into the 20th century."
German and Central European phytotherapy
- Nervous sleeping disorders and restlessness (infusion, standardized extracts)
- Functional gastrointestinal complaints with nervous component (infusion, tincture)
- Herpes labialis (topical Lomaherpan cream)
- Pediatric use for nervousness, colic, and mild fever (dilute infusion)
- Often combined with valerian for insomnia and with fennel/chamomile for digestive complaints
"Lemon balm is one of the most widely prescribed herbal medicines in German-speaking countries. The Commission E positive monograph (1984) confirmed two centuries of systematic clinical observation. Melissa is a component of numerous registered phytopharmaceutical products in Germany, including Klosterfrau Melissengeist (a traditional compound spirit) and Lomaherpan (antiviral topical cream). The EMA/HMPC assessment (2013) confirmed the well-established use for anxiety, sleep, and digestive complaints."
Eclectic American medicine (19th century)
- Nervous excitability, hysteria, and insomnia
- Febrile conditions in children (as a mild diaphoretic)
- Suppressed menstruation (as a mild emmenagogue)
- Digestive complaints with nervous origin
- External application for neuralgic pain
"King's American Dispensatory (Felter and Lloyd, 18th edition, 1898) described lemon balm as 'a mild, pleasant, and efficient diaphoretic and antispasmodic' and listed its primary indications as 'nervous excitability, hysteria, and despondency.' The Eclectics considered it a 'simple but effective nervine' particularly suited for children and those with sensitive constitutions."
[17]
Modern Research
Lemon balm extract (Cyracos) for anxiety and insomnia
Open-label pilot study of standardized Melissa officinalis leaf extract (Cyracos, 600 mg/day, standardized to more than 7% rosmarinic acid and more than 15% hydroxycinnamic acid derivatives) in 20 volunteers with mild-to-moderate anxiety disorders and sleep disturbances over 15 days.
Findings: Anxiety manifestations were reduced by 18% (P < 0.01) and anxiety-associated symptoms by 15% (P < 0.01). Insomnia was reduced by 42% (P < 0.01). Free-floating anxiety, evaluated by the FRSA questionnaire, was reduced by 18%. No adverse events were reported.
Limitations: Small sample size (n=20). Open-label design (no blinding or placebo control). Short treatment duration (15 days). Single commercial product tested. The open-label design means results may be influenced by expectation bias.
[7]
Acute effects of Melissa officinalis on mood and cognitive performance (dose-ranging)
Randomized, double-blind, placebo-controlled, balanced crossover study in 20 healthy young volunteers examining the effects of single doses of dried Melissa officinalis leaf (300, 600, and 900 mg) on mood, cognition, and mathematical processing using the Cognitive Drug Research (CDR) computerized assessment battery.
Findings: The 600 mg dose significantly improved accuracy of attention and speed of mathematical processing. All three doses produced significant improvements in self-rated calmness at 1 hour post-dose. The 300 mg dose increased self-rated speed of mathematical processing. Dose-response was not strictly linear -- the 600 mg dose produced the most consistent cognitive enhancement.
Limitations: Small sample size (n=20). Single-dose acute study; chronic effects not assessed. Healthy young adults only; cannot generalize to clinical anxiety or cognitive impairment populations. Crossover design with 7-day washout periods.
[8]
CNS receptor-binding properties and cognitive enhancement
Randomized, double-blind, placebo-controlled crossover study combining in vitro receptor-binding assays with a human cognitive assessment. Melissa officinalis extract demonstrated human CNS nicotinic and muscarinic acetylcholine receptor-binding properties in vitro. In vivo, single doses (600 and 1000 mg) were administered to 20 healthy young volunteers.
Findings: In vitro: Melissa extract showed concentration-dependent displacement of nicotinic and muscarinic receptor ligands, confirming direct cholinergic receptor interaction. In vivo: both doses modulated mood, with improved calmness and reduced alertness. The 600 mg dose improved the speed of mathematical processing and accuracy of attention, consistent with the 2002 study findings.
Limitations: Small sample size (n=20). Acute single-dose design. In vitro receptor-binding data from crude extract; specific binding compounds not fully characterized. Dual receptor binding (nicotinic + muscarinic) makes mechanistic interpretation complex.
[9]
Attenuation of laboratory-induced stress in healthy volunteers
Randomized, double-blind, placebo-controlled crossover study examining the effects of single doses of Melissa officinalis extract (300 and 600 mg) on psychological and physiological responses to a calibrated laboratory stressor (Defined Intensity Stressor Simulation, DISS) in 18 healthy volunteers.
Findings: The 600 mg dose significantly increased self-rated calmness and reduced self-rated alertness both pre- and post-stress induction. Importantly, the 600 mg dose attenuated the negative effects of the stressor on mood, demonstrating a genuine anti-stress (adaptogenic-like) effect rather than simply sedation. The 300 mg dose also increased self-rated calmness and mathematical processing speed.
Limitations: Small sample size (n=18). Acute single-dose design. Laboratory stressor may not reflect real-world stress. Healthy volunteers without anxiety disorders. Subjective mood measures only.
[10]
Melissa officinalis extract for mild-to-moderate Alzheimer's disease
Randomized, double-blind, placebo-controlled trial in 42 patients with mild-to-moderate Alzheimer's disease (NINCDS-ADRDA criteria). Patients received Melissa officinalis extract (60 drops/day of a 1:1 tincture) or placebo for 16 weeks.
Findings: At 16 weeks, the Melissa group showed significantly better outcomes on both the ADAS-cog cognitive subscale (P < 0.01) and CDR-SB Clinical Dementia Rating (P < 0.01) compared to placebo. Agitation was also significantly reduced in the Melissa group (P < 0.01). The treatment was well tolerated with no significant difference in adverse events between groups.
Limitations: Small sample size (n=42). Single-center study in Iran. Short treatment duration for a neurodegenerative disease (16 weeks). Unusual dosage form (drops of tincture). No acetylcholinesterase inhibitor comparator arm. Results have not been replicated in a larger Western multi-center trial.
[11]
Topical lemon balm extract cream for recurrent herpes labialis
Randomized, double-blind, placebo-controlled trial of topical 1% dried lemon balm extract cream (Lo-701, later marketed as Lomaherpan) in 116 patients with recurrent herpes labialis (at least 4 recurrences/year). Cream was applied four times daily for 5 days beginning at the first signs of recurrence.
Findings: The lemon balm group showed significantly lower symptom scores compared to placebo from day 2 of treatment (P < 0.01 for combined symptom score on physician assessment). Healing time was shortened. Patient self-assessment confirmed superiority of the lemon balm cream. The product was well tolerated with no local adverse reactions reported.
Limitations: Self-reported symptom component. Difficult to ensure complete blinding with topical preparations. Single product (Lo-701) tested; results may not generalize to all Melissa extracts. No active comparator (e.g., acyclovir cream). Effects were symptomatic; no assessment of viral shedding or recurrence rate.
[12]
In vitro antiviral activity of Melissa officinalis oil against herpes simplex virus
In vitro study examining the antiviral activity of Melissa officinalis essential oil and aqueous extract against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in Vero cell cultures, using plaque reduction assays and time-of-addition experiments.
Findings: Melissa essential oil exhibited potent virucidal activity against both HSV-1 and HSV-2 at concentrations well below cytotoxic levels (selectivity index >100 for HSV-1). Time-of-addition experiments demonstrated that the primary mechanism was direct inactivation of free virus particles before cell attachment (virucidal), rather than inhibition of intracellular viral replication. Both the essential oil and the aqueous extract (rich in rosmarinic acid) showed activity, but through partially distinct mechanisms.
Limitations: In vitro study; antiviral concentrations achieved in vivo may differ. Cell culture model does not reflect immune and tissue factors. Essential oil composition varies by chemotype and source. Cannot determine the relative contribution of individual oil components.
[19]
Valerian-lemon balm combination for insomnia
Randomized, double-blind, placebo-controlled, three-arm study comparing a fixed combination of valerian extract (160 mg) and lemon balm extract (80 mg) with low-dose triazolam (0.125 mg benzodiazepine) and placebo in healthy volunteers, assessing sleep quality over a single night using objective and subjective measures.
Findings: The herbal combination improved sleep quality comparably to the low-dose benzodiazepine on several sleep parameters. Both active treatments were superior to placebo. The herbal combination showed no residual morning sedation ('hangover effect'), unlike triazolam.
Limitations: Combination product -- effects of lemon balm alone cannot be separated from valerian's contribution. Low-dose benzodiazepine comparator (0.125 mg triazolam). Healthy volunteers without clinical insomnia. Single-night assessment. Subjective sleep measures predominated.
[13]
Anti-stress effects of lemon balm in food matrix
Randomized, double-blind, placebo-controlled crossover study examining the anti-stress effects of a lemon balm-containing beverage (300 mg standardized Melissa extract containing rosmarinic acid) in healthy volunteers undergoing a calibrated stress battery.
Findings: The lemon balm preparation significantly reduced negative mood effects of the stressor and increased self-rated calmness relative to placebo. Effects were consistent with the earlier Kennedy et al. (2004) stress-attenuation findings and confirmed that the anxiolytic properties are preserved when the extract is delivered in a food/beverage matrix.
Limitations: Food-matrix delivery complicates comparison with capsule/extract studies. Bioavailability may differ from pure extract. Acute single-dose design. Healthy volunteers; cannot extrapolate to clinical anxiety.
[14]
Preparations & Dosage
Infusion (Tea)
Strength: 1.5-4.5 g dried leaf per 150 mL water (Commission E dose range)
Pour 150 mL (approximately 5 oz) of freshly boiled water over 1.5-4.5 g (approximately 1-3 tablespoons) of dried lemon balm leaf. Cover and steep for 5-10 minutes. Strain before drinking. Covering the vessel during steeping is important to minimize loss of volatile aromatic compounds, although the essential oil content is inherently low in dried leaf.
1 cup (150-250 mL) 2-4 times daily
2-4 times daily for therapeutic effect. May be taken as a single dose 30-60 minutes before bedtime for sleep support.
May be used long-term as a daily tea. For specific therapeutic purposes (anxiety, insomnia), reassess after 2-4 weeks. No established maximum duration.
Children 4-12 years: 50-100 mL standard infusion 1-3 times daily. Children over 12: adult dose. Safe and pleasant-tasting for pediatric use.
The most traditional and widely used preparation. Aqueous infusion efficiently extracts rosmarinic acid, flavonoids, and tannins. Essential oil compounds are partially lost during steeping, but the predominant active constituents (phenolic acids, flavonoids) are well-extracted. For the sleep indication, a stronger infusion (4.5 g per cup) taken 30-60 minutes before bed is recommended. Fresh leaf can also be used (approximately 3x the dried weight). Commission E, WHO, ESCOP, and EMA all describe infusion as the primary preparation.
Tincture
Strength: 1:5 in 45% ethanol (dried leaf) or 1:2 in 45-60% ethanol (fresh leaf)
Hydroethanolic extraction of dried or fresh leaf. Dried leaf: standard ratio 1:5 in 45% ethanol. Fresh leaf (preferred by many herbalists for nervine potency): 1:2 in 45-60% ethanol. Macerate for 2-4 weeks with regular agitation, then press and filter.
2-6 mL (40-120 drops) three times daily
Three times daily, or as needed for acute anxiety or stress
May be used for extended periods. Reassess therapeutic need periodically.
Children 4-12 years: 1-2 mL diluted in water, 2-3 times daily (consult practitioner)
Many traditional herbalists prefer the fresh plant tincture (succus or fresh 1:2 extract) for lemon balm, arguing that the volatile aromatic fraction is better preserved. Both dried and fresh plant tinctures provide good extraction of rosmarinic acid and flavonoids. For those avoiding alcohol, the tincture dose can be added to hot water to evaporate some ethanol before drinking. Commission E and ESCOP cite the liquid extract as an alternative to infusion.
Glycerite
Strength: 1:5, 60% glycerin / 40% water (dried herb)
Extraction of dried or fresh leaf in vegetable glycerin and water (typically 60:40 glycerin to water ratio for dried herb, or 75:25 for fresh herb). Macerate for 4-6 weeks with daily agitation, then press and filter.
2-5 mL three times daily
Three times daily
May be used for extended periods
Children 1-4 years: 0.5-1 mL, 2-3 times daily. Children 4-12 years: 1-2.5 mL, 2-3 times daily.
Alcohol-free preparation particularly suitable for children, pregnant or breastfeeding women (at food-level doses), and patients avoiding alcohol. Pleasant sweet taste and gentle action make glycerite the preparation of choice for pediatric nervine and carminative use. Glycerites extract flavonoids and phenolic acids but are less efficient for lipophilic essential oil components compared to ethanolic tinctures.
[6]
Standardized Extract
Strength: Varies. Cyracos: DER approximately 7:1 (methanolic extraction), standardized to more than 7% rosmarinic acid. Other products: DER 4-7:1.
Capsules or tablets containing dried lemon balm extract standardized to rosmarinic acid and/or hydroxycinnamic acid content. Cyracos (Naturex) is the most clinically studied standardized extract, standardized to contain more than 7% rosmarinic acid and more than 15% total hydroxycinnamic acid derivatives.
300-600 mg daily of standardized extract. Cyracos trial dose: 600 mg/day (300 mg twice daily). For cognitive enhancement (based on Kennedy et al.): 600 mg as a single dose. Akhondzadeh Alzheimer's trial: 60 drops/day of 1:1 tincture (equivalent preparation).
1-2 times daily per product label
Clinical trials used 15 days to 16 weeks of continuous treatment safely.
Not well-established for standardized extracts in children; infusion or glycerite preferred.
Standardized extracts provide consistent, quantified doses of the primary active compounds and are the form used in the pivotal anxiety and cognitive function clinical trials. Cyracos is the best-studied product for the anxiety and insomnia indications. For the cognitive enhancement indication, the Kennedy trials used dried leaf powder in capsules (not a concentrated extract), suggesting that even crude preparations can be effective.
Capsule / Powder
Strength: Crude dried leaf powder, typically 300-500 mg per capsule
Dried lemon balm leaf, finely powdered and encapsulated. This is the preparation form used in the Kennedy et al. cognitive function trials.
300-600 mg dried leaf powder, 1-3 times daily. Kennedy trial doses: 300, 600, or 900 mg as single doses.
1-3 times daily
May be used long-term
Not recommended for children in capsule form; use infusion or glycerite instead.
Simple, cost-effective preparation. The Kennedy cognitive function trials (2002, 2003) used this form and demonstrated significant effects, indicating that even crude leaf powder (not concentrated extract) contains sufficient active compounds for therapeutic activity. This may be because the rosmarinic acid content (0.5-7%) is inherently high in the dried leaf.
Essential Oil
Strength: 100% essential oil (Melissae aetheroleum). Minimum quality: citral (geranial + neral) content > 30%.
Steam distillation of fresh aerial parts (herb harvested at onset of flowering). Genuine Melissa essential oil is pale yellow to yellow with a fresh, intense lemon scent. For aromatherapy: 3-5 drops in a diffuser. For topical use: dilute to 1-3% in a carrier oil (e.g., sweet almond, jojoba). NOT for internal use unless specifically formulated for oral administration under professional guidance.
Aromatherapy: 3-5 drops in diffuser or steam inhalation. Topical: 1-3% dilution in carrier oil, applied to temples, wrists, or affected area. Internal use not recommended without professional guidance.
As needed for aromatherapy. Topical: 2-3 times daily.
Short-term use recommended. Reassess if no improvement within 1-2 weeks.
Aromatherapy only for children over 2 years: 1-2 drops in diffuser. Topical: 0.5-1% dilution. Avoid in infants.
Genuine Melissa essential oil is one of the most expensive essential oils due to extremely low yield (0.02-0.37% from fresh herb). This makes it a frequent target for adulteration with cheaper lemongrass (Cymbopogon citratus) or citronella (Cymbopogon nardus) oils, which also contain citral. AUTHENTICATION IS CRITICAL: genuine Melissa oil contains a characteristic ratio of citral, citronellal, beta-caryophyllene, and germacrene D that distinguishes it from adulterants. GC-MS profiling should be requested from suppliers. Commission E does not separately monograph the essential oil, but the ESCOP monograph acknowledges it as a preparation form.
Salve / Ointment
Strength: 1% dried aqueous extract (DER approximately 70:1). Lomaherpan: equivalent to 70 mg dried leaf per gram of cream.
Topical cream containing concentrated lemon balm extract. The clinically studied product is Lomaherpan cream (ViruMedica/Cesra Arzneimittel), containing 1% dried aqueous extract of Melissa officinalis leaf (equivalent to drug-to-extract ratio approximately 70:1). Apply a thin layer to the affected area at the first sign of herpes recurrence (prodromal tingling/burning).
Apply thin layer to affected area (herpes lesion or prodromal site) 2-4 times daily for 5-14 days
2-4 times daily beginning at the earliest symptoms of recurrence
Apply for the duration of the outbreak, typically 5-14 days. Initiate treatment at the earliest prodromal symptoms for optimal efficacy.
Generally considered safe for children. Apply thin layer 2-4 times daily.
This is the preparation form with the strongest clinical evidence for the antiviral (anti-HSV) indication. Koytchev et al. (1999) RCT demonstrated significant symptom reduction and shorter healing time with this formulation. The product is marketed as Lomaherpan in Germany and is available without prescription. It acts through virucidal activity (preventing viral attachment) rather than nucleoside analogue mechanisms (like acyclovir), so it represents a mechanistically distinct antiherpetic approach. No reported local adverse effects or skin sensitization.
[12]
Safety & Interactions
Class 1
Can be safely consumed when used appropriately (AHPA Botanical Safety Handbook)
Contraindications
Allergic reactions to lemon balm are very rare but theoretically possible. Cross-reactivity with other Lamiaceae species (basil, rosemary, lavender, mint) has not been systematically studied but should be considered in individuals with demonstrated Lamiaceae allergy. Contact dermatitis from topical application has been reported in isolated cases.
In vitro studies by Auf'mkolk et al. (1985) demonstrated that Melissa officinalis extract and auto-oxidized constituents (including oxidized phenolics derived from rosmarinic acid) inhibit the binding of TSH receptor antibodies to thyroid membrane preparations. This is a theoretical concern extrapolated from in vitro data. No clinical cases of hypothyroidism caused or worsened by lemon balm consumption have been published in the medical literature. The AHPA Botanical Safety Handbook (2nd edition) classifies Melissa as Class 1 (safe) but notes the theoretical thyroid interaction. Standard tea consumption is unlikely to produce clinically significant thyroid effects, but concentrated extracts at high doses should be used with caution in patients with hypothyroidism or those on thyroid replacement therapy.
Drug Interactions
| Drug / Class | Severity | Mechanism |
|---|---|---|
| Levothyroxine and other thyroid hormone replacement (Thyroid hormones) | moderate | In vitro evidence suggests that oxidized constituents of Melissa extract can inhibit TSH receptor antibody binding (Auf'mkolk et al. 1985). Theoretical concern that high-dose lemon balm could interfere with thyroid hormone action or TSH-mediated feedback. The mechanism involves auto-oxidized phenolic derivatives rather than rosmarinic acid itself. |
| Benzodiazepines, barbiturates, and other CNS depressants (CNS depressants) | minor | Lemon balm modulates GABAergic neurotransmission through multiple mechanisms (GABA-A receptor binding by apigenin, GABA transaminase inhibition by luteolin, and terpenoid CNS effects). Additive sedation is possible when combined with pharmaceutical CNS depressants. |
| Glaucoma medications (pilocarpine, timolol, etc.) (Antiglaucoma agents) | theoretical | One animal study reported increased intraocular pressure following topical ocular application of Melissa extract. The mechanism and clinical relevance to oral consumption are unknown. |
Pregnancy & Lactation
Pregnancy
likely safe
Lactation
likely safe
Lemon balm tea has been consumed by pregnant and breastfeeding women across cultures for centuries without documented adverse fetal or neonatal effects. The EMA assessment notes that traditional use in pregnancy is well-established for the infusion at standard doses, but specific safety studies in pregnant women are lacking (standard precautionary language applied to most herbal products). Commission E does not list pregnancy as a contraindication. The AHPA Botanical Safety Handbook classifies Melissa as Class 1 without pregnancy restrictions. The theoretical thyroid-modulating effect is not considered clinically relevant at standard tea doses. Concentrated extracts, essential oil, and high-dose supplementation should be avoided during pregnancy as a precaution due to the traditional emmenagogue reputation and lack of specific safety data at high doses. Lemon balm tea is considered compatible with breastfeeding by most authorities.
Adverse Effects
References
Monograph Sources
- [1] German Commission E (Bundesinstitut fur Arzneimittel und Medizinprodukte). Commission E Monograph: Melissae folium (Melissa Leaf) -- Positive. Bundesanzeiger (Federal Gazette) (1984)
- [2] World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 2: Folium Melissae. World Health Organization, Geneva (2002) : 180-187
- [3] Committee on Herbal Medicinal Products (HMPC), European Medicines Agency. European Union Herbal Monograph on Melissa officinalis L., folium. European Medicines Agency (2013)
- [4] European Scientific Cooperative on Phytotherapy (ESCOP). ESCOP Monographs: Melissae folium -- Melissa Leaf. ESCOP Monographs, 2nd edition. Thieme, Stuttgart (2003)
- [5] Blumenthal M, Busse WR, Goldberg A, Gruenwald J, Hall T, Riggins CW, Rister RS (eds). The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX (1998) . ISBN: 978-0965555500
- [6] Hoffmann D. Medical Herbalism: The Science and Practice of Herbal Medicine. Healing Arts Press, Rochester, VT (2003) . ISBN: 978-0892817498
Clinical Studies
- [7] Cases J, Ibarra A, Feuillere N, Roller M, Sukkar SG. Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Med J Nutrition Metab (2011) ; 4 : 211-218 . DOI: 10.1007/s12349-010-0045-4
- [8] Kennedy DO, Scholey AB, Tildesley NTJ, Perry EK, Wesnes KA. Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm). Pharmacol Biochem Behav (2002) ; 72 : 953-964 . DOI: 10.1016/S0091-3057(02)00777-3 . PMID: 12062586
- [9] Kennedy DO, Wake G, Savelev S, Tildesley NTJ, Perry EK, Wesnes KA, Scholey AB. Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon Balm) with human CNS nicotinic and muscarinic receptor-binding properties. Neuropsychopharmacology (2003) ; 28 : 1871-1881 . DOI: 10.1038/sj.npp.1300230 . PMID: 12888775
- [10] Kennedy DO, Little W, Scholey AB. Attenuation of laboratory-induced stress in humans after acute administration of Melissa officinalis (Lemon Balm). Psychosom Med (2004) ; 66 : 607-613 . DOI: 10.1097/01.psy.0000132877.72833.71 . PMID: 15272110
- [11] Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M. Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial. J Neurol Neurosurg Psychiatry (2003) ; 74 : 863-866 . DOI: 10.1136/jnnp.74.7.863 . PMID: 12810768
- [12] Koytchev R, Alken RG, Dundarov S. Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis. Phytomedicine (1999) ; 6 : 225-230 . DOI: 10.1016/S0944-7113(99)80013-0 . PMID: 10589440
- [13] Cerny A, Schmid K. Tolerability and efficacy of valerian/lemon balm in healthy volunteers (a double-blind, placebo-controlled, multicentre study). Fitoterapia (1999) ; 70 : 221-228 . DOI: 10.1016/S0367-326X(99)00018-0
- [14] Scholey A, Gibbs A, Neale C, Perry N, Ossoukhova A, Biber V, Buchwald-Werner S, Luber A, Rinaldin S, Stough C. Anti-stress effects of lemon balm-containing foods. Nutrients (2014) ; 6 : 4805-4821 . DOI: 10.3390/nu6114805 . PMID: 25360512
- [15] Savino F, Cresi F, Castagno E, Silvestro L, Oggero R. A randomized double-blind placebo-controlled trial of a standardized extract of Matricariae recutita, Foeniculum vulgare and Melissa officinalis (ColiMil) in the treatment of breastfed colicky infants. Phytother Res (2005) ; 19 : 335-340 . DOI: 10.1002/ptr.1668 . PMID: 16041731
Traditional Texts
- [16] Grieve M. A Modern Herbal: The Medicinal, Culinary, Cosmetic and Economic Properties, Cultivation and Folk-Lore of Herbs, Grasses, Fungi, Shrubs & Trees with Their Modern Scientific Uses. Jonathan Cape, London (1931)
- [17] Felter HW, Lloyd JU. King's American Dispensatory, 18th edition. Ohio Valley Company, Cincinnati (1898)
- [18] Ibn Sina (Avicenna). Al-Qanun fi al-Tibb (The Canon of Medicine). Original manuscript c. 1025 CE; various translations (1025)
Pharmacopeias & Reviews
- [19] Schnitzler P, Schuhmacher A, Astani A, Reichling J. Melissa officinalis oil affects infectivity of enveloped herpesviruses. Phytomedicine (2008) ; 15 : 734-740 . DOI: 10.1016/j.phymed.2008.04.018 . PMID: 18693101
- [20] Auf'mkolk M, Ingbar JC, Kubota K, Amir SM, Ingbar SH. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins. Endocrinology (1985) ; 116 : 1687-1693 . DOI: 10.1210/endo-116-5-1687 . PMID: 2985357
- [21] Kennedy DO, Scholey AB. The psychopharmacology of European herbs with cognition-enhancing properties. Curr Pharm Des (2006) ; 12 : 4613-4623 . PMID: 17168764
- [22] Shakeri A, Sahebkar A, Javadi B. Melissa officinalis L. -- A review of its traditional uses, phytochemistry and pharmacology. J Ethnopharmacol (2016) ; 188 : 204-228 . DOI: 10.1016/j.jep.2016.05.010 . PMID: 27167460
Last updated: 2026-03-01 | Status: published
Unlock the Full Materia Medica
This monograph is part of our complete evidence-based herbal reference. Enter your email to get free, unlimited access to all of our monographs.
No spam, ever. Unsubscribe anytime.
You're In!
You now have full access to all of our herbal monographs.